| Product NDC: | 0068-0508 |
| Proprietary Name: | Rifadin |
| Non Proprietary Name: | rifampin |
| Active Ingredient(s): | 300 mg/1 & nbsp; rifampin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0068-0508 |
| Labeler Name: | Sanofi-Aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050420 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19710521 |
| Package NDC: | 0068-0508-60 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (0068-0508-60) |
| NDC Code | 0068-0508-60 |
| Proprietary Name | Rifadin |
| Package Description | 60 CAPSULE in 1 BOTTLE (0068-0508-60) |
| Product NDC | 0068-0508 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rifampin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19710521 |
| Marketing Category Name | NDA |
| Labeler Name | Sanofi-Aventis U.S. LLC |
| Substance Name | RIFAMPIN |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |